Astrana Health Inc logo

Astrana Health Inc(ASTH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$31.8
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ASTH

11/13/2026: ASTH (1-star) is currently NOT-A-BUY. Pass it for now.

Astrana Health Inc is a technology-powered, risk-bearing healthcare management company that delivers coordinated, value-based medical care through an integrated physician network. The company's primary strengths lie in its scalable, payer-agnostic operating model and robust multi-year revenue growth. Its core investment opportunity centers on capitalizing on the secular shift toward value-based care and successfully integrating major acquisitions like Prospect Health. However, investors must weigh risks such as thin operating margins, increasing balance sheet leverage, and regulatory exposure to government-sponsored healthcare programs. The stock is best suited for growth-oriented investors willing to monitor integration execution, debt levels, and ongoing margin improvements.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitRapid top-line revenue expansion and aggressive scaling in the high-growth value-based care sector match growth criteria.
Momentum investorStrong fit while signal remains positiveStrong institutional attention and consistent multi-year revenue growth attract momentum participants when price trends are favorable.
Value investorMixed fitWhile forward valuation multiples appear reasonable relative to growth, rising goodwill and leverage require careful fundamental scrutiny.
Dividend investorWeak fitAstrana does not pay a cash dividend, focusing entirely on reinvestment and business expansion.
Low-risk investorWeak fitHealthcare regulatory shifts, integration execution risks, and share price volatility make it less suitable for risk-averse portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock experiences fluctuations driven by market sentiment on healthcare policy and quarterly earnings execution.
Valuation riskMediumMultiples depend heavily on sustained high growth and successful integration of large-scale acquisitions.
Competition risk (managed care and value-based enablers)Medium / highIntense competition from large health insurers and specialized care aggregators could pressure margins and network growth.
Business qualityMedium / highThe franchise benefits from strong physician alignment and scalable tech infrastructure, though margins remain thin.
Dividend incomeLow / noneZero dividend yield means investors rely completely on capital appreciation.
Execution riskMedium / highSuccessfully integrating large acquisitions like Prospect Health is critical to realizing projected synergies.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.58B USD
Price to earnings Ratio 29.44
1Y Target Price 51.89
Price to earnings Ratio 29.44
1Y Target Price 51.89
Volume (30-day avg) 360.2K shares
Beta 1.24
52 Weeks Range 18.08 - 51.60
Updated Date 11/15/2026
52 Weeks Range 18.08 - 51.60
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 1.08

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -28.13%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ASTH receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
ASTH has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and strong ownership. In FY2025 versus FY2024, strong revenue growth (+56.4%) is partially offset by negative earnings growth (-47.9%), soft cash generation (FCF margin 3.3%), soft profitability (net margin 0.7%).

Financial Health Rating

★★★★★
ASTH's financial health is supported by solid cash strength, including free-cash-flow generation (3.3% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is ASTH's strongest growth driver at +136.6% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+56.4%, strong) is also strong, while earnings growth (-47.9%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 69.9% and approximately 92.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 23.13% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 13.99%
Vanguard Portfolio Management, LLC 5.28%
Vanguard Capital Management, LLC 3.95%
State Street Corp 3.53%
Dimensional Fund Advisors, Inc. 3.33%

Unit Economics (Per $1K Revenue)

★★★★★
ASTH generates approximately $93 of gross profit, $25 of operating income, and $33 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 2-star rating, with moderate cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 39.21%

Quantitative Style Profile

★★★★★
ASTH has a liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Care Partners SegmentCapitated fees and risk-sharing arrangements from health plans for managing the medical care of assigned patient populations.This is the primary revenue engine, generating income by efficiently managing healthcare costs under risk contracts.
Care Delivery SegmentFee-for-service and value-based clinical revenues from company-operated primary care, multi-specialty, and immediate care clinics.Provides direct clinical services revenue through physical medical facilities and affiliated physician practices.
Care Enablement SegmentAdministrative, management, and technology services fees provided to independent physician groups and health plans.Monetizes the company's administrative and technological infrastructure by assisting external providers.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When After Market
Estimate 0.44
Actual 0.26

Profitability

Profit Margin 1.36%
Operating Margin (TTM) 2.62%

Management Effectiveness

Return on Assets (TTM) 2.79%
Return on Equity (TTM) 9.85%

Valuation

Trailing PE 29.44
Forward PE 8.3
Enterprise Value 2.16B
Price to Sales(TTM) 0.4
Enterprise Value 2.16B
Price to Sales(TTM) 0.4
Enterprise Value to Revenue 0.55
Enterprise Value to EBITDA 10.07
Shares Outstanding 49.67M
Shares Floating 45.71M
Shares Outstanding 49.67M
Shares Floating 45.71M
Percent Insiders 23.13
Percent Institutions 69.89

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.